Northwest Bioth Cmn (NWBO) Social Stream
Northwest Biotherapeutics Inc (NWBO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Northwest Biotherapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued April 10, 2014
NWBO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Northwest Biotherapeutics Inc's number of analysts covering the stock is higher than just about none of of all US stocks.
- Northwest Biotherapeutics Inc's variance in analysts' estimates is less than nearly 100% of all US stocks.
- The upside potential (average analyst target price relative to current price) of NWBO is greater than 98.88% of Pharmaceutical Products stocks.
- Northwest Biotherapeutics Inc's average analyst price target is greater than 29.16% of all US stocks.
Make investment decisions regarding NWBO using the data that counts. Try POWR Ratings for free.